HomeInvestingSPACCytovia Therapeutics CEO Discusses SPAC Deal With Isleworth Healthcare
Cytovia Therapeutics CEO Discusses SPAC Deal With Isleworth Healthcare

The CEO of Cytovia Therapeutics Dr. Daniel Teper joins The Watchlist to discuss the company's focus on building a next-generation immuno-oncology therapeutics platform. The company was founded in 2019, and develops NK-cell and NK-engager antibody platforms to improve tumor-specific targeting in oncology patients. Dr. Teper also highlights the company's SPAC merger with Isleworth Healthcare.

The Watch List

28 Apr 2022

ON AIR
2:00 pm
Market On Close
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
ON AIR
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US